Latest & greatest articles for cardiovascular disease

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cardiovascular disease or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cardiovascular disease and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cardiovascular disease

621. An intensive lifestyle intervention reduced weight and cardiovascular disease risk factors in overweight and obese people with type 2 dia

An intensive lifestyle intervention reduced weight and cardiovascular disease risk factors in overweight and obese people with type 2 dia An intensive lifestyle intervention reduced weight and cardiovascular disease risk factors in overweight and obese people with type 2 diabetes | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here An intensive lifestyle intervention reduced weight and cardiovascular disease risk factors in overweight and obese people with type 2 diabetes Article Text Treatment

Evidence-Based Nursing (Requires free registration)2009

622. Review: brand-name drugs are not more effective than generic versions for treating cardiovascular disease

Review: brand-name drugs are not more effective than generic versions for treating cardiovascular disease Review: brand-name drugs are not more effective than generic versions for treating cardiovascular disease | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: brand-name drugs are not more effective than generic versions for treating cardiovascular disease Article Text Therapeutics Review: brand-name drugs are not more effective than generic versions for treating cardiovascular disease Statistics from Altmetric.com No Altmetric data available

Evidence-Based Medicine (Requires free registration)2009

623. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease

A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease 19064521 2008 12 09 2009 01 13 2017 02 20 1938-3207 88 6 2008 Dec The American journal of clinical nutrition Am. J. Clin. Nutr. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. 1602-10 10.3945/ajcn.2008.26404 High homocysteine concentrations may be neurotoxic and contribute to cognitive decline in older persons. The objective was to examine the effect (...) of supplementation with folic acid, vitamin B-12, and vitamin B-6 on cognitive change in women with cardiovascular disease (CVD) or CVD risk factors. The Women's Antioxidant and Folic Acid Cardiovascular Study is a randomized placebo-controlled trial designed to test the effect of a combination of B vitamins (2.5 mg folic acid/d, 50 mg vitamin B-6/d, and 1 mg vitamin B-12/d) on secondary prevention of CVD. Female health professionals aged >or=40 y (n = 5442) with CVD or >or=3 coronary risk factors in 1998 (after

EvidenceUpdates2009 Full Text: Link to full Text with Trip Pro

624. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease

Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease 19010326 2008 12 16 2009 01 06 2017 02 20 1528-0012 135 6 2008 Dec Gastroenterology Gastroenterology Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. 1935-44, 1944.e1 10.1053/j.gastro.2008.09.018 Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of obesity and metabolic syndrome (MetS). Alanine aminotransferase (ALT) levels (...) are used to detect NAFLD and have also been associated with increased risk for MetS, diabetes mellitus, and cardiovascular disease (CVD). We studied the relationship between ALT levels and these disorders in a long-term follow-up study. Framingham Offspring Heart Study participants (n = 2812; mean age, 44 years; 56% women) were followed for the development of MetS, diabetes, CVD, and all-cause mortality using logistic regression (MetS, diabetes) or Cox proportional hazards models (CVD, all-cause

EvidenceUpdates2009 Full Text: Link to full Text with Trip Pro

625. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study

Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study 19106392 2008 12 24 2009 01 21 2008 12 24 1524-4539 118 25 2008 Dec 16 Circulation Circulation Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study. 2694-701 10.1161/CIRCULATIONAHA.108.792903 Kidney disease is associated with an increased risk (...) of cardiovascular disease (CVD); however, there have been few well-designed prospective studies of this issue in Asian populations. Recent epidemiological studies have suggested that a lower blood pressure level may be associated with an increased risk of CVD in individuals with kidney dysfunction. Using data from 10 community-based cohort studies in Japan, we conducted follow-up on a total of 30 657 individuals 40 to 89 years of age without preexisting CVD or kidney failure and examined the relationship

EvidenceUpdates2009

626. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. 19339045 2009 04 20 2009 05 01 2016 11 22 1474-547X 373 9672 2009 Apr 18 Lancet (London, England) Lancet Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. 1341-51 10.1016/S0140-6736(09)60611-5 The combination of three blood (...) -pressure-lowering drugs at low doses, with a statin, aspirin, and folic acid (the polypill), could reduce cardiovascular events by more than 80% in healthy individuals. We examined the effect of the Polycap on blood pressure, lipids, heart rate, and urinary thromboxane B2, and assessed its tolerability. In a double-blind trial in 50 centres in India, 2053 individuals without cardiovascular disease, aged 45-80 years, and with one risk factor were randomly assigned, by a central secure website, to the Polycap (n

Lancet2009

627. Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study.

Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study. 19515415 2009 07 14 2009 07 31 2016 07 20 1474-547X 374 9684 2009 Jul 11 Lancet (London, England) Lancet Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY (...) ): a phase II, randomised, dose-ranging study. 126-35 10.1016/S0140-6736(09)60870-9 Despite previous reports of potential adverse cardiovascular effects of peroxisome proliferator-activated receptor (PPAR) agonists, the promise for PPAR agonists to positively affect risk of cardiovascular disease in patients with type 2 diabetes is of continued interest. The SYNCHRONY study aimed to establish the glucose-lowering and lipid-modifying effects, and safety profile, of the dual PPAR-alpha and PPAR-gamma

Lancet2009

628. Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study.

Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. OBJECTIVE: To investigate the influence of increasing age on the incidence and remaining lifetime risk of cardiovascular disease and cancer in a cohort of older men. DESIGN: Prospective cohort study. SETTING: United States. PARTICIPANTS: 22,048 male doctors aged 40-84 who were free of major disease in 1982. MAIN OUTCOME MEASURES: Incidence and remaining lifetime risk of major cardiovascular disease (...) (myocardial infarction, stroke, and death from cardiovascular disease) and cancer. RESULTS: 3252 major cardiovascular events and 5400 incident cancers were confirmed over 23 years of follow-up. The incidence of major cardiovascular disease continued to increase to age 100. Beginning at age 80, however, major cardiovascular disease was more likely to be diagnosed at death. The incidence of cancer peaked in those aged 80-89 and then declined. Cancers detected by screening accounted for most of the decline, whereas

BMJ2008 Full Text: Link to full Text with Trip Pro

629. Orthostatic Hypotension and Risk of Cardiovascular Disease in Elderly People: The Rotterdam Study

Orthostatic Hypotension and Risk of Cardiovascular Disease in Elderly People: The Rotterdam Study 18795982 2008 12 04 2008 12 24 2008 12 04 1532-5415 56 10 2008 Oct Journal of the American Geriatrics Society J Am Geriatr Soc Orthostatic hypotension and risk of cardiovascular disease in elderly people: the Rotterdam study. 1816-20 10.1111/j.1532-5415.2008.01946.x To determine the prognostic role of orthostatic hypotension for cardiovascular disease (CVD) and all-cause mortality in elderly people (...) hypotension. During follow-up, 668 subjects had coronary heart disease (CHD) (mean follow-up 6.0 +/- 3.5 years), and 1,835 subjects died (mean follow-up period 7.8 +/- 3.8 years). Orthostatic hypotension increased the risk of CHD (hazard ratio (HR)=1.31, 95% confidence interval (CI)=1.08-1.57) and all-cause mortality (HR=1.22, 95% CI=1.09-1.36), in models adjusted for age and sex. The risk was slightly lower after additional adjustment for cardiovascular risk factors. In analyses stratified for age, the HRs

EvidenceUpdates2008

630. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease.

Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. CONTEXT: Depressive symptoms predict adverse cardiovascular outcomes in patients with coronary heart disease, but the mechanisms responsible for this association are unknown. OBJECTIVE: To determine why depressive symptoms are associated with an increased risk of cardiovascular events. DESIGN AND PARTICIPANTS: The Heart and Soul Study is a prospective cohort study of 1017 (...) with subsequent cardiovascular events (heart failure, myocardial infarction, stroke, transient ischemic attack, or death) was explained by baseline disease severity and potential biological or behavioral mediators. RESULTS: A total of 341 cardiovascular events occurred during 4876 person-years of follow-up. The age-adjusted annual rate of cardiovascular events was 10.0% among the 199 participants with depressive symptoms (PHQ score > or = 10) and 6.7% among the 818 participants without depressive symptoms

JAMA2008 Full Text: Link to full Text with Trip Pro

631. Does obesity modify the effect of blood pressure on the risk of cardiovascular disease? A population-based cohort study of more than one million Swedish men

Does obesity modify the effect of blood pressure on the risk of cardiovascular disease? A population-based cohort study of more than one million Swedish men 18824645 2008 10 14 2008 11 14 2016 11 22 1524-4539 118 16 2008 Oct 14 Circulation Circulation Does obesity modify the effect of blood pressure on the risk of cardiovascular disease? A population-based cohort study of more than one million Swedish men. 1637-42 10.1161/CIRCULATIONAHA.108.772707 Some studies have suggested that increased (...) blood pressure has a stronger effect on the risk of cardiovascular disease (CVD) in lean persons than in obese persons, although this is not a universal finding. Given the inconsistency of this result, we tested it using a large population-based cohort data set. Systolic and diastolic blood pressures (BPs) and body mass index were measured in 1 145 758 Swedish men born between 1951 and 1976 who were in young adulthood (median age 18.2 years). During the register-based follow-up, which lasted until

EvidenceUpdates2008

632. Hypertension Subtype and Risk of Cardiovascular Disease in Chinese Adults

Hypertension Subtype and Risk of Cardiovascular Disease in Chinese Adults 18809800 2008 10 07 2008 10 31 2016 11 22 1524-4539 118 15 2008 Oct 07 Circulation Circulation Hypertension subtype and risk of cardiovascular disease in Chinese adults. 1558-66 10.1161/CIRCULATIONAHA.107.723593 We examined the relationship between hypertension subtype and cardiovascular disease incidence and mortality in Chinese adults. We conducted a prospective cohort study in a nationally representative sample of 169 (...) (SBP <140 and DBP >or=90 mm Hg), and 2 categories of treated hypertension (SBP <140 and DBP <90 mm Hg or SBP >or=140 and/or DBP >or=90 mm Hg). After participants with missing BP values were excluded, 169 577 adults were included in the analyses. Compared with normotensives, relative risks (95% CIs) of cardiovascular disease incidence and mortality were 2.73 (2.60 to 2.86) and 2.53 (2.39 to 2.68) for combined systolic and diastolic hypertension, 1.78 (1.69 to 1.87) and 1.68 (1.58 to 1.78

EvidenceUpdates2008 Full Text: Link to full Text with Trip Pro

633. People with cardiovascular disease identified 5 areas of medication-related problems that influenced adherence and informed decision making

People with cardiovascular disease identified 5 areas of medication-related problems that influenced adherence and informed decision making People with cardiovascular disease identified 5 areas of medication-related problems that influenced adherence and informed decision making | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here People with cardiovascular disease identified 5 areas of medication-related problems that influenced adherence and informed decision making Article Text Qualitative People with cardiovascular

Evidence-Based Nursing (Requires free registration)2008

634. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population-based cohort study

High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population-based cohort study 18668561 2008 08 07 2008 09 18 2016 11 22 0004-3591 58 8 2008 Aug Arthritis and rheumatism Arthritis Rheum. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. 2268-74 10.1002/art.23650 To estimate the 10-year absolute risk of cardiovascular (CV) events in newly diagnosed rheumatoid arthritis (...) 9759681 Arthritis Rheum. 2005 Feb;52(2):412-20 15692992 Arthritis Rheum. 2005 Feb;52(2):402-11 15693010 Arthritis Rheum. 2005 Mar;52(3):722-32 15751097 Arthritis Rheum. 2005 Oct;52(10):3039-44 16200583 Diabetes Care. 2007 May;30(5):1292-3 17290036 N Engl J Med. 2007 Jun 7;356(23):2388-98 17554120 Ann Rheum Dis. 2008 Jan;67(1):64-9 17517756 ACP J Club. 2008 Nov 18;149(5):14 19014181 Adult Age Factors Aged Arthritis, Rheumatoid diagnosis Cardiovascular Diseases epidemiology Cohort Studies Female Humans

EvidenceUpdates2008 Full Text: Link to full Text with Trip Pro

635. Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies

Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies 18458139 2008 07 29 2008 08 20 2016 10 19 1935-5548 31 8 2008 Aug Diabetes care Diabetes Care Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies. 1672-8 10.2337/dc08-0167 Observational studies (...) assessing the association of combination therapy of metformin and sulfonylurea on all-cause and/or cardiovascular mortality in type 2 diabetes have shown conflicting results. We therefore evaluated the effects of combination therapy of sulfonylureas and metformin on the risk of all-cause mortality and cardiovascular disease (CVD) among people with type 2 diabetes. A MEDLINE search (January 1966-July 2007) was conducted to identify observational studies that examined the association between combination

EvidenceUpdates2008 Full Text: Link to full Text with Trip Pro

636. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA)

Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA) 18574091 2008 06 24 2008 07 08 2016 12 03 1538-3679 168 12 2008 Jun 23 Archives of internal medicine Arch. Intern. Med. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). 1333-9 10.1001 (...) /archinte.168.12.1333 Coronary artery calcium (CAC) and carotid intima-media thickness (IMT) are noninvasive measures of atherosclerosis that consensus panels have recommended as possible additions to risk factor assessment for predicting the probability of cardiovascular disease (CVD) occurrence. Our objective was to assess whether maximum carotid IMT or CAC (Agatston score) is the better predictor of incident CVD. A prospective cohort study of subjects aged 45 to 84 years in 4 ethnic groups, who were

EvidenceUpdates2008 Full Text: Link to full Text with Trip Pro

637. Relations between dietary sodium and potassium intakes and mortality from cardiovascular disease: the Japan Collaborative Cohort Study for Evaluation of Cancer Risks

Relations between dietary sodium and potassium intakes and mortality from cardiovascular disease: the Japan Collaborative Cohort Study for Evaluation of Cancer Risks 18614741 2008 07 10 2008 07 31 2015 11 19 1938-3207 88 1 2008 Jul The American journal of clinical nutrition Am. J. Clin. Nutr. Relations between dietary sodium and potassium intakes and mortality from cardiovascular disease: the Japan Collaborative Cohort Study for Evaluation of Cancer Risks. 195-202 Limited evidence is available (...) about the relations between sodium and potassium intakes and cardiovascular disease in the general population. The objective was to investigate relations between sodium and potassium intakes and cardiovascular disease in Asian populations whose mean sodium intake is generally high. Between 1988 and 1990, a total of 58,730 Japanese subjects (n = 23,119 men and 35,611 women) aged 40-79 y with no history of stroke, coronary heart disease, or cancer completed a lifestyle questionnaire including food

EvidenceUpdates2008

638. Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease

Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease 18549850 2008 06 13 2008 07 15 2016 10 19 0002-9149 101 12 2008 Jun 15 The American journal of cardiology Am. J. Cardiol. Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease. 1741-6 10.1016/j.amjcard.2008.02.060 Chronic kidney disease (CKD) increases cardiovascular risk and mortality (...) . However, traditional cardiovascular risk factors do not adequately account for the substantial increase in mortality observed in CKD. The aim of this study was to examine the relative contributions of novel cardiovascular risk factors to the risk between CKD and mortality. The study population included 4,680 consecutive new patients from a tertiary care preventive cardiology program from 1996 to 2005. Estimated glomerular filtration rate was calculated using the Modification of Diet in Renal Disease

EvidenceUpdates2008 Full Text: Link to full Text with Trip Pro

639. Inflammation and cardiovascular events in individuals with and without chronic kidney disease

Inflammation and cardiovascular events in individuals with and without chronic kidney disease 18401337 2008 06 02 2008 07 07 2016 10 19 1523-1755 73 12 2008 Jun Kidney international Kidney Int. Inflammation and cardiovascular events in individuals with and without chronic kidney disease. 1406-12 10.1038/ki.2008.75 Inflammation and chronic kidney disease predict cardiovascular events. Here we evaluated markers of inflammation including fibrinogen, albumin and white blood cell count (...) in individuals with and without stages 3-4 chronic kidney disease to assess inflammation as a risk factor for adverse events, the synergy between inflammation and chronic kidney disease, and the prognostic ability of these inflammatory markers relative to that of C-reactive protein. Using Atherosclerosis Risk in Communities and Cardiovascular Health Study data, inflammation was defined by worst quartile of at least 2 of these 3 markers. In Cox regression models, inflammation was assessed as a risk factor

EvidenceUpdates2008 Full Text: Link to full Text with Trip Pro

640. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial

Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial 18474884 2008 05 13 2008 06 24 2017 02 20 1544-1717 6 3 2008 May-Jun Annals of family medicine Ann Fam Med Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. 218-27 10.1370/afm.854 We wanted to determine the effect of promoting the effective communication of absolute cardiovascular disease (CVD) risk and shared decision (...) . 1997 Mar;44(5):681-92 9032835 JAMA. 2002 Dec 4;288(21):2701-8 12460093 BMJ. 2003 Sep 27;327(7417):741-4 14512488 Fam Pract. 1998 Oct;15(5):480-92 9848436 Adult Aged Cardiovascular Diseases etiology prevention & control Decision Making Decision Support Techniques Female Health Behavior Humans Male Middle Aged Patient Education as Topic methods Patient Participation Patient Satisfaction Physician-Patient Relations Physicians, Family Primary Health Care methods Risk Assessment PMC2384995 2008 5 14 9 0

EvidenceUpdates2008 Full Text: Link to full Text with Trip Pro